- Champignon Brands recently started trading on the Canadian Securities Exchange (CSE)
- The company also enters into definitive agreement to acquire Artisan Growers Ltd
- SHRM specializes in medicinal-mushroom, mushroom-infused products
Champignon Brands Inc. (CSE: SHRM), a wellness company specializing in the formulation and distribution of a group of artisanal-mushroom health supplements, recently began trading on the Canadian Securities Exchange (CSE). In February 2020, SHRM successfully completed an initial public offering (IPO) through lead agent PI Financial Corp. Additionally, Champignon Brands will look to secure a listing on the Frankfurt Stock Exchange and a quotation on the OTC Marketplace in the United States as soon as is feasible (http://cnw.fm/LP3Xt).
“We’ve been assembling a dedicated roster of mycologists and health and wellness professionals to formulate several distinctive lines of premium fungi extracts,” Champignon CEO Gareth Birdsall stated in a news release. “The overall product portfolio is tailored for conscious consumers looking to support mental health and bolster cognitive performance through medicinal mushroom-based products.”
As Champignon Brands continues to bolster its product portfolio, the company also recently announced that it entered into a definitive agreement to acquire Artisan Growers Ltd., a British-Columbia-based, craft-mushroom cultivator and supplier. Champignon’s plan is to integrate Artisan Growers’ craft-mushroom production capacity into its existing medicinal-mushroom manufacturing, formulation and distribution infrastructure.
Champignon Brands’ focus is to continue to control its supply chain directly to the end user (http://cnw.fm/5hRvI). Artisan Growers operates a craft-mushroom cultivation facility that can produce an array of organic craft mushroom varietals including lion’s mane, chaga, reishi and agaricus blazei.
SHRM’s dedication is to the cultivation, distribution and proliferation of artisanal-medical mushrooms and associated CPGs (Consumer Packaged Goods). The company crafts its increasingly evolving portfolio with the health-conscious consumer in mind, as evidenced by its flagship brand, Vitality Superteas. A vertically integrated producer of medicinal mushrooms and related products, Champignon Brands is based in Vancouver, British Columbia.
With a passion for transforming conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, SHRM and its offerings align with the medical research community’s renewed interest in mushrooms’ health benefits. “Mushrooms contain protein, vitamins, minerals, and antioxidants. These can have various health benefits,” reported a recent Medical News Today article titled ‘What is the Nutritional Value of Mushrooms?’ (http://cnw.fm/59mCa). The article also states that “the antioxidant content in mushrooms may help prevent lung, prostate, breast and other types of cancer, according to the National Cancer Institute.” Harnessing the power of the humble mushroom, Champignon Brands is helping to shape the health and wellness product landscape. Champignon Brands has its premium family of organic, sustainable, vegan and non-GMO (genetically modified organisms) mushroom and mushroom-infused formulations. The company’s Vitality Superteas products includes Nourish Force Supertea, a blend of reishi tyobus tea mix; Mighty Recharge Supertea, created with lion’s mane tropical green ginseng tea mix; and Brain Enhance Supertea, a blend of cordycep hibiscus and berries tea mix.
Aside from its impressive product lineup, the company also has its research and development/product formulation partnership. Champignon and Drip Coffee Social Ltd. entered into this partnership to facilitate Drip Coffee Social infusing Champignon’s proprietary, mushroom-extract blend into a suite of cold-brew coffee products and signature in-house formulations (http://cnw.fm/gd3MT). Champignon sees considerable potential in the CPG space.
The expectation is that the worldwide, functional-food marketplace that the company is working to enter will reach $34.3 billion by 2024. For 2020, Champignon Brands’ strategy includes the development of cGMP (Current Good Manufacturing Practice) formulations of bioactive compounds extracted from plants and fungi (http://cnw.fm/46Pan).
Champignon Brands is aggressively pursuing its mission of researching and distributing premium-medicinal, mushrooms-infused products. Of note to investors is that the company is targeting high-margin markets and optimizing its e-commerce and fulfillment infrastructure. Champignon Brands continues to promote the health and wellness benefits of functional mushrooms while at the same time offering the potential for significant investor return on investment.
For more information, visit the company’s website at www.ChampignonBrands.com
NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
